申请人:Pfizer Inc.
公开号:US04636498A1
公开(公告)日:1987-01-13
An improved antiinflammatory composition and method of treating inflammation which employs a combination of an antiinflammatory agent (e.g. indomethacin or an oxicam) with a histamine-H.sub.2 antagonist selected from the group consisting of 2-guanidino-4-(4-imidazolyl)thiazole, 2-guanidino-4-(2-methyl-4-imidazolyl )thiazole, 2-(N-benzyl-N'-guanidino)-4-(2-methyl-4-imidazolyl)thiazole, 2-(N-pentyl-N'-guanidino)-4-(2-methyl-4-imidazolyl)thiazole and 2-guanidino-4-[2-(hexylamino)-4-imidazolyl]thiazole.
一种改进的抗炎组合物及治疗炎症的方法,使用抗炎剂(例如吲哚美辛或氧化康)与组选自2-胍基-4-(4-咪唑基)噻唑、2-胍基-4-(2-甲基-4-咪唑基)噻唑、2-(N-苄基-N'-胍基)-4-(2-甲基-4-咪唑基)噻唑、2-(N-戊基-N'-胍基)-4-(2-甲基-4-咪唑基)噻唑和2-胍基-4-[2-(己基氨基)-4-咪唑基]噻唑的组胺H.sub.2拮抗剂的组合治疗炎症。